The hypothesis that endogenous PGE2 mediates defective thick ascending limb (TAL) Cl reabsorption (percent delivered load: FRCl%) in rats with vitamin D-induced chronic hypercalcemia (HC) was tested by measuring FRCl% in loop segments microperfused in vivo in HC and control rats treated acutely with indomethacin (Indo) or its vehicle, and obtaining the corresponding outer medullary (PGE2]. Microperfusion conditions were developed in which FRCl% was exclusively furosemide sensitive. To determine the cellular mechanism, tubules were perfused acutely with forskolin (FSK), cAMP, or the protein kinase C inhibitor staurosporine (SSP). Outer medullary |PGE2] in HC rats was 9 to 10 times greater than control and could be normalized by Indo. FRCl% was 20% lower in HC rats infused with vehicle, and Indo, FSK, and cAMP returned FRCl% to normal despite sustained HC. Indo or FSK had no effect on FRCl% in control rats and Indo did not prevent inhibition of FRCl% by luminal PGE2 (1 μM). Luminal SSP ( 10-7, 10-8 M) in HC did not return FRCl% to control values. We conclude that impaired TAL FRCl% in HC occurs at a precAMP site and is due to endogenous PGE2 and not to HC.
CITATION STYLE
Peterson, L. N., McKay, A. J., & Borzecki, J. S. (1993). Endogenous prostaglandin E2 mediates inhibition of rat thick ascending limb CI reabsorption in chronic hypercalcemia. Journal of Clinical Investigation, 91(6), 2399–2407. https://doi.org/10.1172/JCI116473
Mendeley helps you to discover research relevant for your work.